| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.2 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |